{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:31:11Z","timestamp":1708475471053},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,19]]},"DOI":"10.7759\/cureus.54491","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T05:00:50Z","timestamp":1708405250000},"source":"Crossref","is-referenced-by-count":0,"title":["Fatal Differentiation Syndrome Complicating Acute Promyelocytic Leukemia Treatment: A Case Report"],"prefix":"10.7759","author":[{"given":"Umair","family":"Khizer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavana","family":"Annam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akasha","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasninder  S","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)91415-5","article-title":"15\/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia","volume":"1","author":"Rowley JD","year":"1977","unstructured":"Rowley JD, Golomb HM, Dougherty C. 15\/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet. 1977, 1:549-50. 10.1016\/s0140-6736(77)91415-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.1961744","article-title":"Drug treatment options for acute promyelocytic leukemia","volume":"23","author":"Ferrara F","year":"2022","unstructured":"Ferrara F, Molica M, Bernardi M. Drug treatment options for acute promyelocytic leukemia. Expert Opin Pharmacother. 2022, 23:117-27. 10.1080\/14656566.2021.1961744","journal-title":"Expert Opin Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-204834","article-title":"Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome","volume":"114","author":"Luesink M","year":"2009","unstructured":"Luesink M, Pennings JL, Wissink WM, et al.. Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 2009, 114:5512-21. 10.1182\/blood-2009-02-204834","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2011.048","article-title":"Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment","volume":"3","author":"Rego EM","year":"2011","unstructured":"Rego EM, De Santis GC. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment. Mediterr J Hematol Infect Dis. 2011, 3:e2011048. 10.4084\/MJHID.2011.048","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-512640","article-title":"How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia","volume":"123","author":"Sanz MA","year":"2014","unstructured":"Sanz MA, Montesinos P. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia. Blood. 2014, 123:2777-82. 10.1182\/blood-2013-10-512640","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1982","article-title":"Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial","volume":"35","author":"Platzbecker U","year":"2017","unstructured":"Platzbecker U, Avvisati G, Cicconi L, et al.. Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial. J Clin Oncol. 2017, 35:605-12. 10.1200\/JCO.2016.67.1982","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco F","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, et al.. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013, 369:111-21. 10.1056\/NEJMoa1300874","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin","volume":"111","author":"de la Serna J","year":"2008","unstructured":"de la Serna J, Montesinos P, Vellenga E, et al.. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008, 111:3395-402. 10.1182\/blood-2007-07-100669","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217160-fatal-differentiation-syndrome-complicating-acute-promyelocytic-leukemia-treatment-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T05:00:52Z","timestamp":1708405252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217160-fatal-differentiation-syndrome-complicating-acute-promyelocytic-leukemia-treatment-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.54491","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,19]]}}}